146 related articles for article (PubMed ID: 20537977)
1. Liver and bone.
Guañabens N; Parés A
Arch Biochem Biophys; 2010 Nov; 503(1):84-94. PubMed ID: 20537977
[TBL] [Abstract][Full Text] [Related]
2. Management of osteoporosis in liver disease.
Guañabens N; Parés A
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):438-45. PubMed ID: 21546334
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in chronic liver disease.
Guañabens N; Parés A
Liver Int; 2018 May; 38(5):776-785. PubMed ID: 29479832
[TBL] [Abstract][Full Text] [Related]
4. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
5. [Osteoporosis in liver cirrhosis].
Guañabens N; Parés A
Gastroenterol Hepatol; 2012; 35(6):411-20. PubMed ID: 22483016
[TBL] [Abstract][Full Text] [Related]
6. Bone disorders in chronic liver disease.
Collier J
Hepatology; 2007 Oct; 46(4):1271-8. PubMed ID: 17886334
[TBL] [Abstract][Full Text] [Related]
7. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
Guañabens N; Parés A; Ros I; Caballería L; Pons F; Vidal S; Monegal A; Peris P; Rodés J
J Hepatol; 2005 Apr; 42(4):573-7. PubMed ID: 15763344
[TBL] [Abstract][Full Text] [Related]
8. Bone disorders in cholestatic liver diseases.
Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
[TBL] [Abstract][Full Text] [Related]
9. [Post-transplantation osteoporosis].
Negri AL; Plantalech LC; Russo Picasso MF; Otero A; Sarli M
Medicina (B Aires); 1999; 59(6):777-86. PubMed ID: 10752228
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of bone disease and fractures post transplant.
Bia M
Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in Parkinson's disease.
Invernizzi M; Carda S; Viscontini GS; Cisari C
Parkinsonism Relat Disord; 2009 Jun; 15(5):339-46. PubMed ID: 19346153
[TBL] [Abstract][Full Text] [Related]
12. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
13. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
14. Management of bone loss after organ transplantation.
Cohen A; Sambrook P; Shane E
J Bone Miner Res; 2004 Dec; 19(12):1919-32. PubMed ID: 15537434
[TBL] [Abstract][Full Text] [Related]
15. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis.
Guañabens N; Cerdá D; Monegal A; Pons F; Caballería L; Peris P; Parés A
Gastroenterology; 2010 Jun; 138(7):2348-56. PubMed ID: 20178794
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
17. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D
Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123
[TBL] [Abstract][Full Text] [Related]
18. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
